Thyroid Gland Carcinoma — Trials

Thyroid Gland Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

389 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 96
Recruiting: 39
Ph III recruiting: 5
Growth YoY: −15%
Industry share: 14%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 32.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (42)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05949424	OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults(OPTI-DOSE)	unknown	Phase 4	30	University Medical Center GroningenOTHER	1	Nov 29, 2023	clinicaltrials
NCT05247476	Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.	unknown	Phase 4	50	Zhongshan Hospital Xiamen UniversityOTHER	1	Feb 18, 2022